title: Preclinical studies with trimetrexate: a review of conclusions and unanswered questions.
authors.affiliation: Chemotherapy Department, Warner-Lambert Company, Ann Arbor, MI 48106.
authors.forename: R C
authors.initials: RC
authors.lastname: Jackson
authors.forename: W R
authors.initials: WR
authors.lastname: Leopold
authors.forename: K L
authors.initials: KL
authors.lastname: Hamelehle
authors.forename: D W
authors.initials: DW
authors.lastname: Fry
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D006801:Humans; D011799:Quinazolines / Q000494:pharmacology* / Q000627:therapeutic use; D016597:Trimetrexate
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D016597:Trimetrexate